Quidel (QDEL) is cheap for me now. The market somewhat exaggerated its sale. This company has a lot to offer even after the COVID crisis. Are there any other positive news and their balance sheet? Research yourself, strong company! Iam in at 125.5 and waitin for some good premium, expect a mild pump on Monday, but I'm waiting for at least a 50-100 %...
It has been growing dramatically as part of the pandemic, which is not surprising. What I see now. The paper is moving in a downward channel (highlighted in blue). In February it broke through the uptrend line that started in March 20. And now it is trading closer to the lower boundary of the channel. The maximum that the paper can go down, I see at $104-$105....
Quidel Corporation develops, manufactures and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases and toxicology worldwide. The company during 2020 benefited greatly from the pandemic thanks to its Covid-19 QuickVue test that recently received FDA...
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. Why I'm buying right now: Price target is from low 165.00 to high 341.00 2019 earnings - 72.92 M -> 2020 earnings -...
Accumulate $110-120 to swing long into end of year
QDEL is at golden pocket and is oversold. Ignore the death cross. Earnings is too good. It should go back into golden cross.
Pretty simple techical situation in QDEL stock. Consolidation in 2018-2019, then a massive upside to $300, and now another big consolidation between $150-300. Buy @ $140-150, TP $260-280-300, SL $120.
with the emergency authorization of their at home COVID test and testing a very strong support with the RSI nicely below 30, we could see a reverse to the upside on QDEL. it must hold at the current level though. keeping a close eye on this one
Upcoming earning estimate is 9.94, we will see the real earnings tomorrow. Everything else is looking good, so oversold. The gap from November could be filled pretty quickly. Possible LT, PT 278, then 401.